Clinical Trial Update: A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

This document describes a Phase II clinical trial evaluating HSK44459 for moderate to severe plaque psoriasis, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• HSK44459

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Psoriasis | Phase 2 | Status: NOT_YET_RECRUITING